Physician

Eric Weston Innes, M.D.

According to 2025 Medicare claims, Eric Innes, M.D. (NPI: 1841618444) practices anesthesiology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Innes is affiliated with the Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under the REACH model.

Innes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 371 traditional Medicare patients, billed 9,478 HCPCS/CPT codes, and received $258,765 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,428 prescription claims across 498 beneficiaries totaling $47,638 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 12 records totaling $246. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,509 to $258,765. Similarly, Part D prescription costs have moved sharply higher in recent years, from $22,630 to $47,638. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	39	43	$10,509
2019	56	63	$15,091
2020	N/R	N/R	N/R
2021	80	566	$23,627
2022	301	3,767	$201,564
2023	370	7,334	$294,217
2024	371	9,478	$258,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	166	311	$22,630
2020	282	702	$60,101
2021	11	24	$405
2022	260	1,359	$27,157
2023	380	2,767	$69,623
2024	498	2,428	$47,638

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	632	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	149	265	$65
20553	Injection of trigger points, 3 or more muscles	100	163	$41
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	148	257	$12
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	161	1,112	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	434	15,152	$11,143
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	227	6,213	$5,348
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	122	3,428	$3,249
Meloxicam	Meloxicam	386	14,105	$2,962
Methocarbamol	Methocarbamol	155	5,371	$2,599

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$246	Salix Pharmaceuticals, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric Weston Innes, M.D.?

Tedicare shows public-source Medicare data for Eric Weston Innes, M.D. (NPI 1841618444), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric Weston Innes, M.D. have ACO affiliation data?

Eric Weston Innes, M.D. is shown with ACO affiliation data for Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to Eric Weston Innes, M.D.?

Eric Weston Innes, M.D. is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does Eric Weston Innes, M.D. have Open Payments data?

Eric Weston Innes, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.